Long- versus short-acting beta 2-agonists. Implications for drug therapy.
Boulet
L P
LP
Centre de Pneumologie de l'Hôpital Laval, Université Laval, Sainte-Foy, Quebec, Canada.
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D006801:Humans
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D003692:Delayed-Action Preparations